Lyme Disease (Borrelia burgdorferi)

Overview

Plain-Language Overview

Lyme Disease is an infection caused by the bacterium Borrelia burgdorferi, which is transmitted to humans through the bite of infected black-legged ticks. It primarily affects the skin, joints, nervous system, and sometimes the heart. Early symptoms often include a characteristic bull's-eye rash, fever, fatigue, and muscle aches. If untreated, the infection can spread and cause more serious problems such as arthritis, neurological issues like facial palsy, and heart rhythm disturbances. The disease is most common in certain regions of the United States, especially the Northeast and upper Midwest. Understanding the symptoms and timing of tick exposure is important for recognizing this illness.

Clinical Definition

Lyme Disease is a multisystem inflammatory disorder caused by infection with the spirochete bacterium Borrelia burgdorferi, transmitted by the bite of infected Ixodes ticks. The core pathology involves dissemination of the spirochete from the initial skin site to various tissues, leading to characteristic clinical manifestations including erythema migrans, lymphocytic meningitis, cranial neuropathies, arthritis, and carditis. The disease progresses through stages: early localized, early disseminated, and late disseminated infection. The immune response to the spirochete contributes to tissue inflammation and damage. Diagnosis relies on clinical presentation supported by serologic testing. Untreated infection can result in chronic symptoms and significant morbidity.

Inciting Event

Bite from an infected Ixodes tick introduces Borrelia burgdorferi into the skin.
Tick attachment for ≥36-48 hours is usually required for transmission of the spirochete.
Initial localized infection at the bite site triggers erythema migrans rash and early symptoms.

Latency Period

3 to 30 days after tick bite before onset of erythema migrans rash and early symptoms.
Disseminated symptoms such as arthritis or neurologic involvement may appear weeks to months later.
Late manifestations can occur months to years after initial infection if untreated.

Diagnostic Delay

Absence or unrecognized erythema migrans rash leads to missed early diagnosis.
Nonspecific symptoms like fatigue, fever, and arthralgia mimic other illnesses causing misattribution.
Low sensitivity of serologic testing in early disease delays confirmation.
Lack of awareness of tick exposure history in non-endemic areas contributes to delay.

Patient Population

Children and adults living in endemic rural or suburban areas are most commonly affected.
Both males and females are susceptible, with slight male predominance in some studies.
Peak incidence occurs in spring and summer months corresponding to tick activity.
Individuals with frequent outdoor occupational or recreational exposure have higher incidence.

Risk Factors

Exposure to Ixodes ticks in endemic areas is the primary risk factor for infection.
Outdoor activities such as hiking or camping in wooded or grassy regions increase risk.
Living in or traveling to Northeastern, Mid-Atlantic, and Upper Midwestern United States where Lyme disease is endemic.
Delayed tick removal increases likelihood of transmission of Borrelia burgdorferi.
Lack of protective clothing or insect repellents during tick season raises infection risk.

Clinical Presentation

Signs & Symptoms

Erythema migrans rash appearing days to weeks after tick bite is pathognomonic.
Flu-like symptoms including fever, malaise, headache, and myalgias are common early signs.
Bell palsy or other cranial neuropathies indicate early neurologic involvement.
Migratory arthralgias progressing to frank arthritis in large joints occur in later stages.
Cardiac symptoms such as palpitations, syncope, or chest pain may indicate Lyme carditis.

History of Present Illness

Initial presentation often includes a slowly expanding erythema migrans rash at the tick bite site.
Early symptoms include fever, malaise, headache, myalgias, and arthralgias.
Weeks to months later, patients may develop migratory polyarthritis, facial nerve palsy, or meningitis.
Late disease can present with chronic arthritis or encephalopathy.
Symptoms often progress from localized to disseminated multisystem involvement.

Past Medical History

Prior tick bites or previous Lyme disease infection increase suspicion for reinfection or relapse.
History of immunosuppression may alter disease presentation or severity.
No specific chronic illnesses are required but outdoor exposure history is relevant.

Family History

No known heritable genetic predisposition to Lyme disease exists.
Family members may share environmental exposure risk if living in endemic areas.
No familial syndromes are associated with susceptibility to Borrelia burgdorferi infection.

Physical Exam Findings

Erythema migrans rash with central clearing is the hallmark early finding.
Lymphadenopathy near the site of tick bite may be present.
Facial nerve palsy (Bell palsy) can be observed in early disseminated disease.
Arthritis typically involves large joints such as the knee with swelling and effusion.
Cardiac conduction abnormalities such as AV block may be detected on exam.

Physical Exam Maneuvers

Neurologic exam assessing cranial nerves to detect facial palsy.
Joint examination for swelling, warmth, and decreased range of motion in large joints.
Cardiac auscultation to evaluate for new murmurs or irregular rhythms indicating carditis.
Skin inspection for characteristic erythema migrans and other rashes.
Musculoskeletal exam to assess for migratory arthritis or myalgias.

Common Comorbidities

Other tick-borne infections such as babesiosis and anaplasmosis often co-occur.
Post-treatment Lyme disease syndrome with persistent fatigue and musculoskeletal pain.
Allergic reactions to tick bites or antibiotic therapy may complicate management.
Autoimmune arthritis can be triggered or unmasked by Lyme disease.
Neurologic disorders including peripheral neuropathy may coexist or follow infection.

Diagnostic Workup

Diagnostic Criteria

Diagnosis is primarily clinical, based on the presence of erythema migrans rash or a history of tick exposure with compatible symptoms. Confirmatory diagnosis involves a two-tiered serologic testing approach: an initial enzyme-linked immunosorbent assay (ELISA) followed by a Western blot for IgM and IgG antibodies against Borrelia burgdorferi. Early infection may have negative serology, so clinical judgment is critical. Additional tests such as cerebrospinal fluid analysis may be used in cases with neurological involvement.

Pathophysiology

Key Mechanisms

Infection with the spirochete bacterium Borrelia burgdorferi leads to immune system activation and local tissue inflammation.
Spirochete dissemination through the bloodstream causes multisystem involvement including skin, joints, heart, and nervous system.
Erythema migrans rash results from localized cutaneous infection and inflammatory response.
Chronic arthritis and neurologic symptoms arise from persistent immune-mediated inflammation triggered by bacterial antigens.
Autoimmune-like mechanisms may contribute to post-treatment Lyme disease syndrome.

Involvement	Details
Organs	Skin serves as the portal of entry and site of early localized infection in Lyme disease.
	Joints are commonly affected in late Lyme disease causing arthritis with swelling and pain.
	Central nervous system involvement leads to neurologic manifestations such as meningitis and facial nerve palsy.
Tissues	Skin is the initial site of infection where erythema migrans rash develops as a hallmark of early Lyme disease.
	Synovial tissue is involved in Lyme arthritis characterized by inflammation and swelling of large joints.
	Nervous tissue can be affected in neuroborreliosis causing meningitis, cranial neuropathies, and radiculoneuritis.
Cells	Macrophages phagocytose Borrelia burgdorferi and present antigens to activate adaptive immunity.
	B cells produce specific antibodies against Borrelia burgdorferi surface antigens aiding in bacterial clearance.
	T helper cells coordinate immune response by releasing cytokines that activate macrophages and B cells.
Chemical Mediators	Interleukin-6 (IL-6) is elevated during Lyme disease and contributes to systemic inflammation and fever.
	Tumor necrosis factor-alpha (TNF-α) mediates inflammatory responses causing tissue damage in affected organs.
	C-reactive protein (CRP) is an acute phase reactant elevated in active infection and inflammation.

Treatments

Pharmacological Treatments

Doxycycline
- Mechanism:
  - Inhibits bacterial protein synthesis by binding to the 30S ribosomal subunit of Borrelia burgdorferi.
- Side effects:
  - Photosensitivity
  - Gastrointestinal upset
  - Tooth discoloration in children
- Clinical role:
  - First-line
Amoxicillin
- Mechanism:
  - Inhibits bacterial cell wall synthesis by binding penicillin-binding proteins in Borrelia burgdorferi.
- Side effects:
  - Allergic reactions
  - Gastrointestinal upset
  - Rash
- Clinical role:
  - First-line
Cefuroxime axetil
- Mechanism:
  - Second-generation cephalosporin that inhibits bacterial cell wall synthesis in Borrelia burgdorferi.
- Side effects:
  - Allergic reactions
  - Gastrointestinal upset
  - Diarrhea
- Clinical role:
  - First-line
Ceftriaxone
- Mechanism:
  - Third-generation cephalosporin that inhibits bacterial cell wall synthesis, used for disseminated or neurologic Lyme disease.
- Side effects:
  - Injection site reactions
  - Gallbladder sludge
  - Allergic reactions
- Clinical role:
  - Second-line

Non-pharmacological Treatments

Removal of attached tick within 24-36 hours to reduce transmission risk of Borrelia burgdorferi.
Supportive care including analgesics and anti-inflammatory measures for symptom relief.
Physical therapy for residual joint stiffness or neurologic deficits after infection.

Prevention

Pharmacological Prevention

Single-dose doxycycline prophylaxis within 72 hours of tick removal reduces Lyme disease risk.
Tick repellents containing DEET applied to skin reduce tick attachment and infection risk.
No licensed vaccine currently available for Lyme disease prevention in humans.
Prompt antibiotic treatment of early infection prevents progression to disseminated disease.
Avoidance of unnecessary antibiotic use to prevent resistance and adverse effects.

Non-pharmacological Prevention

Avoidance of tick-infested areas especially during peak tick activity in spring and summer.
Wearing protective clothing such as long sleeves and pants to reduce skin exposure.
Performing thorough tick checks after outdoor activities to remove ticks promptly.
Landscaping modifications to reduce tick habitat near homes and recreational areas.
Education on proper tick removal using fine-tipped tweezers to minimize infection risk.

Outcome & Complications

Complications

Lyme arthritis causing chronic joint inflammation and damage.
Lyme carditis leading to high-grade AV block and potentially fatal arrhythmias.
Neuroborreliosis with meningitis, radiculopathy, or encephalopathy.
Chronic neurologic symptoms such as cognitive dysfunction and peripheral neuropathy.
Post-treatment Lyme disease syndrome with prolonged fatigue and musculoskeletal pain.

Short-term Sequelae	Long-term Sequelae
Acute arthritis with joint swelling and pain typically in knees within weeks to months. Facial nerve palsy causing unilateral facial weakness during early disseminated phase. Meningitis or radiculoneuritis presenting with headache, neck stiffness, and radicular pain. Cardiac conduction abnormalities such as transient AV block during early infection. Fatigue and malaise persisting beyond initial infection but improving with treatment.	Chronic Lyme arthritis with recurrent joint swelling despite antibiotic therapy. Persistent neurologic deficits including peripheral neuropathy and cognitive impairment. Post-treatment Lyme disease syndrome characterized by chronic fatigue and musculoskeletal pain. Cardiac fibrosis and permanent conduction system damage after Lyme carditis. Autoimmune phenomena potentially triggered by Borrelia burgdorferi infection.

Short-term Sequelae

Long-term Sequelae

Acute arthritis with joint swelling and pain typically in knees within weeks to months.
Facial nerve palsy causing unilateral facial weakness during early disseminated phase.
Meningitis or radiculoneuritis presenting with headache, neck stiffness, and radicular pain.
Cardiac conduction abnormalities such as transient AV block during early infection.
Fatigue and malaise persisting beyond initial infection but improving with treatment.

Chronic Lyme arthritis with recurrent joint swelling despite antibiotic therapy.
Persistent neurologic deficits including peripheral neuropathy and cognitive impairment.
Post-treatment Lyme disease syndrome characterized by chronic fatigue and musculoskeletal pain.
Cardiac fibrosis and permanent conduction system damage after Lyme carditis.
Autoimmune phenomena potentially triggered by Borrelia burgdorferi infection.

Differential Diagnoses

Lyme Disease (Borrelia burgdorferi) versus Early Viral Exanthem

Lyme Disease (Borrelia burgdorferi)	Early Viral Exanthem
History of tick bite or exposure in endemic area	Recent contact with individuals with viral illness or no tick exposure
Gradual onset of erythema migrans rash expanding over days to weeks	Rapid onset of generalized rash with systemic symptoms resolving within days
Positive ELISA and confirmatory Western blot for Borrelia burgdorferi	Negative serology for Borrelia burgdorferi antibodies

Lyme Disease (Borrelia burgdorferi) versus Southern Tick-Associated Rash Illness (STARI)

Lyme Disease (Borrelia burgdorferi)	Southern Tick-Associated Rash Illness (STARI)
Caused by Borrelia burgdorferi transmitted by Ixodes ticks	Associated with Amblyomma americanum tick and unknown pathogen
Rash with systemic symptoms such as fever, arthralgia, and fatigue	Mild illness with localized rash and minimal systemic symptoms
Requires antibiotic therapy for resolution and prevention of complications	Often resolves without antibiotic treatment

Lyme Disease (Borrelia burgdorferi) versus Cellulitis

Lyme Disease (Borrelia burgdorferi)	Cellulitis
Normal or mildly elevated white blood cell count without neutrophilia	Elevated white blood cell count with neutrophilic predominance
Erythema migrans rash with central clearing and less tenderness	Localized skin infection with erythema, warmth, and tenderness
Requires doxycycline or amoxicillin targeting Borrelia burgdorferi	Rapid improvement with beta-lactam antibiotics targeting common skin bacteria

Lyme Disease (Borrelia burgdorferi) versus Rheumatoid Arthritis

Lyme Disease (Borrelia burgdorferi)	Rheumatoid Arthritis
Acute or subacute mono- or oligoarticular arthritis following infection	Chronic symmetric polyarthritis lasting months to years
Negative rheumatoid factor; positive Lyme serology	Positive rheumatoid factor and anti-CCP antibodies
Joint effusion without erosions in early Lyme arthritis	Joint space narrowing and erosions on X-ray

Lyme Disease (Borrelia burgdorferi) versus Secondary Syphilis

Lyme Disease (Borrelia burgdorferi)	Secondary Syphilis
History of tick exposure in endemic areas	History of unprotected sexual contact
Erythema migrans rash localized at tick bite site	Diffuse maculopapular rash including palms and soles
Positive Borrelia burgdorferi serology with ELISA and Western blot	Positive rapid plasma reagin (RPR) and treponemal antibody tests